Live Breaking News & Updates on Demonstrated Significantly Improved

Nevro Reports First Quarter 2021 Financial Results and Updates 2021 Guidance
News provided by
Share this article
Share this article
REDWOOD CITY, Calif., May 5, 2021 /PRNewswire/  Nevro Corp. (NYSE: NVRO), a global medical device company that is providing innovative, evidence-based solutions for the treatment of chronic pain, today reported its financial results for the first quarter ended March 31, 2021 and provided updated 2021 guidance.
First Quarter and Recent Highlights
First Quarter 2021 Worldwide Revenue of $88.6 Million; Increase of 1% Compared to Prior Year and Increase of 8% Compared to 2019
First Quarter 2021 Net Loss from Operations of $22.5 Million; First Quarter 2021 Non-GAAP Adjusted EBITDA of Negative $6.6 Million
Updates Full Year 2021 Revenue Guidance to $440 Million to $450 Million ....

United States , Redwood City , D Keith Grossman , Exchange Commission , Nevro Corp , Prior Year , First Quarter , Full Year , First Major Omnia Upgrade , New Trial Stimulator Module , Painful Diabetic Neuropathy , Demonstrated Significantly Improved , Sustained Outcomes , Comprehensive New Brand Identity Combining Nevro , Innovative Technologies , Advanced Therapies , End To Patient , Non Surgical Refractory Back Pain , Conference Call Information , Looking Statements , Private Securities Litigation Reform Act , Annual Report , Comprehensive Loss , Accepted Accounting Principles , Blow Case , High Case ,